scanX
Home
Alpa Laboratories

Alpa Laboratories

112.00
+1.22
(1.10%)
Market Cap (₹ Cr.)
₹238
52 Week High
144.50
Book Value
₹
52 Week Low
69.90
PE Ratio
11.44
PB Ratio
1.45
PE for Sector
42.34
PB for Sector
19.73
ROE
%
ROCE
13.64 %
Dividend Yield
0.00 %
EPS
₹
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Formulations
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
20.82 %
Net Income Growth
33.33 %
Cash Flow Change
-58.99 %
ROE
18.12 %
ROCE
10.75 %
EBITDA Margin (Avg.)
9.11 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
17
9
14
14
22
16
14
18
23
12
17
18
18
18
17
27
21
21
24
25
19
18
24
34
26
36
29
32
29
24
20
30
28
30
35
31
28
27
32
Expenses
14
6
8
14
19
13
13
15
19
11
14
14
19
16
16
23
22
19
23
22
19
14
21
30
24
29
23
26
27
21
19
25
20
27
29
25
20
21
22
EBITDA
3
3
6
0
3
3
1
3
4
2
3
4
-1
2
1
3
-1
2
1
3
-0
4
3
4
2
7
6
6
2
3
1
5
9
3
6
6
7
6
10
Operating Profit %
2 %
25 %
38 %
-12 %
3 %
11 %
-2 %
11 %
4 %
3 %
12 %
18 %
-6 %
7 %
1 %
11 %
-16 %
7 %
4 %
9 %
-6 %
11 %
8 %
9 %
5 %
8 %
13 %
13 %
-5 %
6 %
-42 %
10 %
32 %
-5 %
10 %
9 %
15 %
3 %
13 %
Depreciation
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
1
0
0
1
1
1
1
Interest
0
0
0
0
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
1
3
6
-0
2
2
1
3
3
1
2
4
-1
2
1
3
-1
2
1
3
-1
3
2
4
2
6
6
5
2
3
0
5
8
3
6
5
7
5
10
Tax
-0
0
0
0
3
0
0
0
3
0
0
0
2
-0
0
0
1
0
0
0
2
0
0
0
2
0
0
0
3
0
0
0
4
0
0
1
3
0
2
Net Profit
1
3
6
-0
-1
2
1
3
0
1
2
4
-3
2
1
3
-3
2
1
3
-2
3
2
4
-2
6
6
5
-4
3
0
5
5
3
6
5
4
5
8
EPS in ₹
0.27
1.41
2.79
-0.20
-0.43
1.18
0.34
1.20
0.23
0.62
1.10
1.84
-1.33
0.97
0.30
1.40
-1.28
0.85
0.47
1.47
-0.84
1.54
1.09
1.80
-0.96
3.07
2.73
2.57
-1.74
1.27
0.10
2.45
2.09
1.44
2.75
2.15
1.70
2.44
3.63
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
128
145
129
127
129
131
150
165
178
192
Fixed Assets
5
5
5
6
6
6
7
9
7
11
Current Assets
113
118
108
96
93
94
120
137
149
160
Capital Work in Progress
0
0
0
0
0
1
2
0
0
0
Investments
0
0
23
41
59
68
62
86
90
109
Other Assets
123
141
100
79
64
56
80
70
81
72
Total Liabilities
42
51
31
23
23
21
33
33
33
30
Current Liabilities
41
50
30
23
22
21
32
29
30
28
Non Current Liabilities
1
1
0
1
0
0
0
5
3
2
Total Equity
87
94
98
103
106
110
118
132
145
162
Reserve & Surplus
66
73
77
82
85
89
96
111
124
141
Share Capital
21
21
21
21
21
21
21
21
21
21
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
42
-37
-9
-19
-20
5
4
-8
8
-6
Investing Activities
37
-7
1
-16
-15
-11
6
-16
1
-12
Operating Activities
-2
-25
-8
-7
-1
18
-1
2
10
4
Financing Activities
7
-6
-2
4
-5
-1
-0
5
-3
2
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
56.66 %
56.66 %
56.66 %
56.66 %
57.29 %
57.29 %
57.29 %
57.29 %
57.29 %
57.29 %
57.29 %
57.29 %
57.29 %
57.29 %
57.29 %
FIIs
0.00 %
0.00 %
0.00 %
0.09 %
0.56 %
0.21 %
0.14 %
0.00 %
0.00 %
0.00 %
0.11 %
0.95 %
0.50 %
0.36 %
0.74 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.01 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.05 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
43.34 %
43.34 %
43.34 %
43.20 %
42.15 %
42.50 %
42.56 %
42.71 %
42.69 %
42.69 %
42.60 %
41.75 %
42.20 %
42.35 %
41.96 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Torrent Pharmaceuticals
3,181.00 1,07,301.00 61.66 10,785.75 11.59 1,656 17.36 44.06
Ajanta Pharma
3,051.65 36,977.73 42.26 4,293.31 11.77 816 10.84 46.66
Gland Pharma
1,768.50 28,939.46 41.84 5,834.96 50.97 772 -15.74 51.44
Eris Lifesciences
1,408.80 18,730.20 53.76 2,032.96 19.85 397 -21.22 58.77
Caplin Point Laboratories
1,957.50 14,935.92 30.26 1,761.04 15.65 461 12.63 50.39
Marksans Pharma
312.10 13,982.37 40.28 2,227.83 16.55 315 16.59 60.70
Shilpa Medicare
926.00 8,908.75 155.20 1,159.77 8.64 32 1,042.68 59.39
Jeena Sikho Lifecare
1,979.00 4,840.02 144.97 207.35 40.06 34 - 70.72
Hester Biosciences
2,489.30 2,023.91 86.23 315.18 12.07 21 107.67 46.08
Amrutanjan Health Care
702.25 2,017.67 42.45 192.42 12.50 21 72.26 42.30

Corporate Action

Technical Indicators

RSI(14)
Neutral
46.33
ATR(14)
Less Volatile
4.57
STOCH(9,6)
Neutral
49.35
STOCH RSI(14)
Neutral
74.20
MACD(12,26)
Bullish
0.15
ADX(14)
Weak Trend
14.61
UO(9)
Bearish
44.27
ROC(12)
Uptrend And Accelerating
0.45
WillR(14)
Neutral
-46.32
Bearish
3
Neutral
4
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Intraday Screeners
Price & Volume Screeners
Technical Screeners
Candlestick Screeners
Fundamental Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.